{"id":"https://openalex.org/W2017568077","doi":"https://doi.org/10.1002/hep.21225","title":"A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B","display_name":"A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B","publication_year":2006,"publication_date":"2006-06-27","ids":{"openalex":"https://openalex.org/W2017568077","doi":"https://doi.org/10.1002/hep.21225","mag":"2017568077","pmid":"https://pubmed.ncbi.nlm.nih.gov/16799983"},"language":"en","primary_location":{"id":"doi:10.1002/hep.21225","doi":"https://doi.org/10.1002/hep.21225","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hep.21225","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.21225","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.21225","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100959431","display_name":"Minde Zeng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800570007","display_name":"Renji Hospital","ror":"https://ror.org/03ypbx660","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800570007"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"MinDe Zeng","raw_affiliation_strings":["Renji Hospital, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renji Hospital, Shanghai, China","institution_ids":["https://openalex.org/I2800570007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074096979","display_name":"Yimin Mao","orcid":"https://orcid.org/0000-0002-2928-3425","observed_orcids":["https://orcid.org/0000-0002-2928-3425"]},"institutions":[{"id":"https://openalex.org/I2800570007","display_name":"Renji Hospital","ror":"https://ror.org/03ypbx660","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800570007"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"YiMin Mao","raw_affiliation_strings":["Renji Hospital, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renji Hospital, Shanghai, China","institution_ids":["https://openalex.org/I2800570007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103656906","display_name":"Guangbi Yao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"GuangBi Yao","raw_affiliation_strings":["Jing-An Qu Hospital, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jing-An Qu Hospital, Shanghai, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100389473","display_name":"Hao Wang","orcid":"https://orcid.org/0000-0002-5573-5851","observed_orcids":["https://orcid.org/0000-0002-5573-5851"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hao Wang","raw_affiliation_strings":["Beijing People's Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beijing People's Hospital, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056241757","display_name":"Jinlin Hou","orcid":"https://orcid.org/0000-0001-8230-8583","observed_orcids":["https://orcid.org/0000-0001-8230-8583"]},"institutions":[{"id":"https://openalex.org/I4210103346","display_name":"Nanfang Hospital","ror":"https://ror.org/01eq10738","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103346"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"JinLin Hou","raw_affiliation_strings":["NanFang Hospital, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NanFang Hospital, Guangzhou, China","institution_ids":["https://openalex.org/I4210103346"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076126795","display_name":"YaoZong Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155028","display_name":"Jinan Infectious Disease Hospital","ror":"https://ror.org/05mp6hg50","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210155028"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"YaoZong Wang","raw_affiliation_strings":["Infectious Disease Hospital, Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Infectious Disease Hospital, Jinan, China","institution_ids":["https://openalex.org/I4210155028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036222488","display_name":"Beulah Ji","orcid":"https://orcid.org/0000-0002-9944-348X","observed_orcids":["https://orcid.org/0000-0002-9944-348X"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Beulah N. Ji","raw_affiliation_strings":["GlaxoSmithKline, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, London, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006379562","display_name":"Chai-Ni P. Chang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chai-Ni P. Chang","raw_affiliation_strings":["GlaxoSmithKline, Raleigh-Durham, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Raleigh-Durham, NC","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112514339","display_name":"Keith F. Barker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Keith F. Barker","raw_affiliation_strings":["GlaxoSmithKline, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, London, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5074096979"],"corresponding_institution_ids":["https://openalex.org/I2800570007"],"apc_list":{"value":2900,"currency":"USD","value_usd":2900},"apc_paid":null,"fwci":6.9815,"has_fulltext":true,"cited_by_count":73,"citation_normalized_percentile":{"value":0.97358114,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"44","issue":"1","first_page":"108","last_page":"116"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adefovir-dipivoxil","display_name":"adefovir dipivoxil","score":1.0},{"id":"https://openalex.org/keywords/hbeag-positive-chronic-hepatitis-b","display_name":"HBeAg-positive hepatitis B","score":0.9340000152587891},{"id":"https://openalex.org/keywords/ymdd-mutants","display_name":"YMDD mutants","score":0.675000011920929},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8059999942779541},{"id":"https://openalex.org/keywords/alt-normalization","display_name":"ALT normalization","score":0.6710000038146973},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.6430000066757202},{"id":"https://openalex.org/keywords/chinese-patients","display_name":"Chinese patients","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C2779517838","wikidata":"https://www.wikidata.org/wiki/Q353551","display_name":"Adefovir","level":5,"score":0.9612220525741577},{"id":"https://openalex.org/C2775940106","wikidata":"https://www.wikidata.org/wiki/Q10478733","display_name":"HBeAg","level":5,"score":0.8267917037010193},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7759957909584045},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6212815046310425},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.616092324256897},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6067273616790771},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.5923287868499756},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.5280787944793701},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.46475377678871155},{"id":"https://openalex.org/C45189115","wikidata":"https://www.wikidata.org/wiki/Q502159","display_name":"Serology","level":3,"score":0.4403912425041199},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.42080551385879517},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.38617509603500366},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.34842991828918457},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.348416268825531},{"id":"https://openalex.org/C2777410769","wikidata":"https://www.wikidata.org/wiki/Q2282887","display_name":"HBsAg","level":4,"score":0.29423853754997253},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2510341703891754},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.14956605434417725},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10438129305839539},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002681","descriptor_name":"China","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004279","descriptor_name":"DNA, Viral","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006513","descriptor_name":"Hepatitis B e Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006515","descriptor_name":"Hepatitis B virus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006515","descriptor_name":"Hepatitis B virus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/hep.21225","doi":"https://doi.org/10.1002/hep.21225","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hep.21225","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.21225","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},{"id":"pmid:16799983","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16799983","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology (Baltimore, Md.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/hep.21225","doi":"https://doi.org/10.1002/hep.21225","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hep.21225","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.21225","source":{"id":"https://openalex.org/S156174673","display_name":"Hepatology","issn_l":"0270-9139","issn":["0270-9139","1527-3350"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hepatology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320330117","display_name":"Ruijin Hospital","ror":"https://ror.org/01hv94n30"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017568077.pdf","grobid_xml":"https://content.openalex.org/works/W2017568077.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1965258712","https://openalex.org/W1969934038","https://openalex.org/W1987843876","https://openalex.org/W1991994232","https://openalex.org/W1996800586","https://openalex.org/W2004054613","https://openalex.org/W2006698257","https://openalex.org/W2012673014","https://openalex.org/W2014837723","https://openalex.org/W2045347800","https://openalex.org/W2049234248","https://openalex.org/W2071291950","https://openalex.org/W2086360009","https://openalex.org/W2090126805","https://openalex.org/W2093604720","https://openalex.org/W2120667564","https://openalex.org/W2122070481","https://openalex.org/W2122259487","https://openalex.org/W2146003334","https://openalex.org/W2147194699","https://openalex.org/W2161280033","https://openalex.org/W2293495463","https://openalex.org/W2338794667","https://openalex.org/W2393327590","https://openalex.org/W2419630967","https://openalex.org/W4255557530"],"related_works":["https://openalex.org/W2352474603","https://openalex.org/W2373831526","https://openalex.org/W2364534313","https://openalex.org/W1979133579","https://openalex.org/W2353401951","https://openalex.org/W2381323879","https://openalex.org/W2362238823","https://openalex.org/W2359732956","https://openalex.org/W2377303875","https://openalex.org/W7217307114"],"abstract_inverted_index":{"Four":[0],"hundred":[1],"and":[2,55,62,76,97,129,162,187,193,220,228],"eighty":[3],"Chinese":[4,223],"subjects":[5,51,82,105,173,224,249],"with":[6,83,93,98,118,125,131,153,174,210,225,247],"hepatitis":[7,13,42],"B":[8,14,43],"e":[9],"antigen":[10],"(HBeAg)-positive":[11],"chronic":[12],"(CHB)":[15],"were":[16,101,168,205],"enrolled":[17],"in":[18,38,72,78,103,149,185,222],"a":[19,35],"multicenter,":[20],"double-blind,":[21],"randomized,":[22],"placebo-controlled":[23],"study":[24,239],"of":[25,40,81,88,113,172,179,198,235],"adefovir":[26],"dipivoxil":[27],"(ADV)":[28],"10":[29,212,253],"mg":[30,213,254],"once":[31],"daily.":[32,255],"There":[33],"was":[34,183,195,218],"significant":[36],"difference":[37],"reduction":[39,112],"serum":[41,73],"virus":[44],"(HBV)":[45],"DNA":[46,75,86,95,111,120,127],"after":[47,143],"12":[48],"weeks":[49,217],"between":[50,189],"who":[52,57,135],"received":[53,58,137],"ADV":[54,138,211,252],"those":[56,171],"the":[59,79,147,190,233],"placebo":[60,148],"(3.4":[61],"0.1":[63],"log10":[64],"copies/mL,":[65,92,116,123],"respectively,":[66],"P":[67],"<":[68],".001).":[69],"Further":[70],"reductions":[71],"HBV":[74,85,94,110,119,126,156,203],"increases":[77],"proportion":[80],"an":[84,243],"level":[87],"at":[89,106,157],"most":[90],"10(5)":[91,122],"undetectable,":[96,128],"ALT":[99,132],"normalization":[100],"observed":[102],"ADV-treated":[104],"week":[107,150],"52":[108,216],"(median":[109],"4.5":[114],"log(10)":[115],"67%":[117],"<or=":[121],"28%":[124],"79%":[130],"normalization).":[133],"Subjects":[134,152],"initially":[136],"lost":[139],"some":[140],"treatment":[141,166,191,209],"benefit":[142],"being":[144],"rerandomized":[145],"to":[146,165,170,232],"40.":[151],"YMDD":[154],"mutant":[155],"baseline":[158],"had":[159],"virological,":[160],"biochemical,":[161],"serological":[163],"responses":[164],"that":[167],"similar":[169,184],"wild-type":[175],"HBV.":[176],"The":[177,238],"incidence":[178],"clinically":[180],"adverse":[181],"events":[182],"nature":[186],"severity":[188],"groups,":[192],"there":[194],"no":[196],"evidence":[197],"renal":[199],"toxicity.":[200],"No":[201],"adefovir-related":[202],"mutations":[204],"identified.":[206],"In":[207],"conclusion,":[208],"daily":[214],"over":[215],"safe":[219],"effective":[221],"HBeAg-positive":[226],"CHB":[227],"did":[229],"not":[230],"lead":[231],"emergence":[234],"drug":[236],"resistance.":[237],"is":[240],"continuing":[241],"for":[242],"additional":[244],"4":[245],"years":[246],"all":[248],"on":[250],"open-label":[251]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}